These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39081646)

  • 1. Differences in the Effects of Beta-Blockers Depending on Heart Rate at Discharge in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.
    Kim YI; Ahn MS; Yoo BS; Kim JY; Son JW; Park YJ; Kim SH; Kang DR; Lee HY; Kang SM; Cho MC
    Int J Heart Fail; 2024 Jul; 6(3):119-126. PubMed ID: 39081646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.
    Ahn MS; Yoo BS; Son JW; Yu MH; Kang DR; Lee HY; Jeon ES; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Kim KH; Cho MC; Kim SY
    J Korean Med Sci; 2020 Aug; 35(33):e278. PubMed ID: 32830467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Implications of Heart Rate Control in Heart Failure With Atrial Fibrillation: Multi-Center Prospective Observation Registry (CODE-AF Registry).
    Song S; Ko JS; Lee HA; Choi EK; Cha MJ; Kim TH; Park JK; Lee JM; Kang KW; Shim J; Uhm JS; Kim J; Kim C; Kim JB; Park HW; Joung B; Park J
    Front Cardiovasc Med; 2022; 9():787869. PubMed ID: 35391851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intersection of atrial fibrillation and heart failure with mildly reduced and preserved ejection fraction in >400 000 participants in the Get With The Guidelines-Heart Failure Registry.
    Patel RB; Greene SJ; Xu H; Alhanti B; Peterson P; Yancy CW; Piccini J; Fonarow GC; Vaduganathan M
    Eur J Heart Fail; 2023 Jan; 25(1):63-73. PubMed ID: 36343200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
    Li SJ; Sartipy U; Lund LH; Dahlström U; Adiels M; Petzold M; Fu M
    Circ Heart Fail; 2015 Sep; 8(5):871-9. PubMed ID: 26243796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate determines the beneficial effects of beta-blockers on cardiovascular outcomes in patients with heart failure and atrial fibrillation.
    Hudoyo AW; Fukuda H; Imazu M; Shindo K; Fu H; Iwata Y; Ito S; Kitakaze M
    Hypertens Res; 2019 Nov; 42(11):1716-1725. PubMed ID: 31209398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discharge heart rate and 1-year clinical outcomes in heart failure patients with atrial fibrillation.
    Xing F; Zheng X; Zhang L; Hu S; Bai X; Hu D; Li B; Li J
    Chin Med J (Engl); 2022 Jan; 135(1):52-62. PubMed ID: 34982055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of heart rate in elderly with systolic heart failure and concomitant atrial fibrillation.
    Barywani S; Petzold M
    Scand Cardiovasc J; 2017 Aug; 51(4):190-196. PubMed ID: 28393567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction.
    Matsumoto S; Henderson AD; Shen L; Kondo T; Yang M; Campbell RT; Anand IS; de Boer RA; Desai AS; Lam CSP; Maggioni AP; Martinez FA; Packer M; Redfield MM; Rouleau JL; Van Veldhuisen DJ; Vaduganathan M; Zannad F; Zile MR; Jhund PS; Solomon SD; McMurray JJV
    Eur J Heart Fail; 2024 Aug; ():. PubMed ID: 39215677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status　- Report From the Japanese Nationwide Multicenter Registry.
    Temma T; Nagai T; Watanabe M; Kamada R; Takahashi Y; Hagiwara H; Koya T; Nakao M; Omote K; Kamiya K; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
    Circ J; 2020 Feb; 84(3):397-403. PubMed ID: 32009066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Blockers are associated with increased B-type natriuretic peptide levels differently in men and women in heart failure with preserved ejection fraction.
    Harada E; Mizuno Y; Ishii M; Ishida T; Yamada T; Kugimiya F; Yasue H
    Am J Physiol Heart Circ Physiol; 2022 Aug; 323(2):H276-H284. PubMed ID: 35714176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction.
    Yang E; Vaishnav J; Song E; Lee J; Schulman S; Calkins H; Berger R; Russell SD; Sharma K
    ESC Heart Fail; 2022 Oct; 9(5):2918-2927. PubMed ID: 35712815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction.
    Fukui A; Tanino T; Yamaguchi T; Hirota K; Saito S; Okada N; Akioka H; Shinohara T; Yufu K; Takahashi N
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):682-688. PubMed ID: 31985099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of resting heart rate in atrial fibrillation patients with heart failure with reduced ejection fraction.
    Suzuki S; Motoki H; Kanzaki Y; Maruyama T; Hashizume N; Kozuka A; Yahikozawa K; Kuwahara K
    Heart Vessels; 2020 Aug; 35(8):1109-1115. PubMed ID: 32144498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation.
    Ahn MS; Yoo BS; Son JW; Park YJ; Lee HY; Jeon ES; Kang SM; Choi DJ; Kim KH; Cho MC; Kim SY; Kang DR; Go TH
    J Korean Med Sci; 2021 Oct; 36(40):e252. PubMed ID: 34664798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of patients with anemia and renal dysfunction in hospitalized heart failure with preserved ejection fraction (from the CN-HF registry).
    Jin X; Cao J; Zhou J; Wang Y; Han X; Song Y; Fan Y; Chen Z; Xu D; Yang X; Dong W; Li L; Chen L; Zhong Q; Fu M; Hu K; Zhou J; Ge J;
    Int J Cardiol Heart Vasc; 2019 Dec; 25():100415. PubMed ID: 31508483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Beta-blocker therapy on rehospitalization rates in women versus men with heart failure and preserved ejection fraction.
    Farasat SM; Bolger DT; Shetty V; Menachery EP; Gerstenblith G; Kasper EK; Najjar SS
    Am J Cardiol; 2010 Jan; 105(2):229-34. PubMed ID: 20102924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
    Lam PH; Dooley DJ; Deedwania P; Singh SN; Bhatt DL; Morgan CJ; Butler J; Mohammed SF; Wu WC; Panjrath G; Zile MR; White M; Arundel C; Love TE; Blackman MR; Allman RM; Aronow WS; Anker SD; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2017 Oct; 70(15):1861-1871. PubMed ID: 28982499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.